Portfolio

Marcyrl

  • Marcyrl, an African pharmaceutical manufacturer is focused on improving access to specialty generic medicines in Egypt
  • Marcyrl’s primary ambition is to improve access to and distribution of specialty pharmaceutical products in Egypt and throughout Africa through its international export network.
  • Marcyrl is committed to discovering, researching, developing and manufacturing innovative and promising new products and therapies dedicated entirely to human health.
Country Egypte
Acquisition March 2023
Status In portfolio
Strategy Small & Mid Caps Africa
  • Case studies

Novamed, Marcyrl, Avacare Health, Best Health
Improving the provision of medical care in African countries

18 July 2024